histor colgat show clear relationship advertis spend
top-lin growth correl broke recent year colgat
re-bas restor advertis spend north sale
avail competit dynam consum prefer chang dramat
share leader necessarili competit advantag becam
clear ramp advertis wasnt enough wed begun question whether
mega-brand strategi center colgat equiti could work past
intrigu build dialogu around new product new
channel initi past year begin profession skin care
acquisit announc decemb sure small suggest
chang colgat particular notion invest behind oral care brand
colgat expand geograph reach struck us signific given
colgat gener bias toward promot namesak equiti rather
pursu real portfolio approach build market share oral still
challeng us sort materi answer question
whether one-off initi element comprehens
cohes adjust compani playbook
grow add follow friday call know also
work done revit scale core portfolio weve known
total re-launch sinc global consum stapl confer septemb
understand accompani price increas high single-digit
math mean could benefit total compani revenu
growth without assum increment unit/shar growth heel new
formul global advertis campaign would seem good
momentum build hill strong quarter prescript diet
come re-launch scienc diet new hill e-commerc subscript
servic busi could well reacceler mid single-digit growth
cl quarterli annual ep usd
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
execut strategi remark market share
leav us construct compani potenti
reacceler growth bolster profit
also expect share continu
bake degre takeout premium
assum cl share trade premium
large-cap stapl peer group trade
premium market ep
estim reflect ep declin
assum cl share trade premium
large-cap stapl peer group trade
premium market downsid case
ep yoy
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
friday colgat report ep compar consensu
barclay research lower tax rate contribut upsid versu
stock sure expect would reinvest year
colgat question degre think posit
surpris wide rang portfolio activ increment spend support
perhap solv miss compani effect ep rebas
didnt much impact revenu trend far optimist
what come still think take time new playbook proven closer
easi comparison construct global price environ benefit result
hard believ alreadi two year sinc colgat organ revenu growth
deceler dramat rang nearli uninterrupt year histori
trend better cours colgat hasnt alon regard prove
resili longer chang consum prefer global rise
small nimbl upstart chang competit landscap perhap result also
took compani longer acknowledg might need thing differ
past order reacceler growth
histor colgat show clear relationship advertis spend
top-lin growth strong market share posit regular cadenc new
product activ categori develop opportun usag trade-up
stand reason colgat invest advertis gener saw solid return
sure worri see advertis dollar shrink
know migrat tradit
advertis in-stor activ thu account reduct gross sale also
becam clear pull back effect tie incred pressur
fx rate put compani dollar base latin america
correl broke recent year colgat re-bas
restor advertis spend north sale avail competit
dynam chang dramat local competitor gain share sever market
vari platform wasnt natur across multipl price tier
consum prefer chang fast case across categori
share leader necessarili competit advantag becam clear
ramp advertis wasnt enough wed begun question whether mega-
brand strategi centr colgat equiti could work past see
histor colgat shown clear relationship advertis spend
top line growth correl broken recent year
intrigu build dialogu around new product new
channel initi past year begin profession skin care
acquisit announc decemb sure small suggest
chang colgat particular notion invest behind oral care brand
colgat expand geograph reach launch elmex china e-
commerc brazil pharmaci channel struck us signific given colgat
gener bias toward promot namesak equiti rather pursu
real portfolio approach build market share oral still challeng us
sort materi answer question whether one-off
initi element comprehens cohes adjust compani
playbook either way new brand subcategori take time build illustr
success slow share build colgat vedshakti line india nation
share consecut increas quarter sinc launch modern
trade consecut increas last quarter
grow add weve plenti work term ad
terribl confid effort part comprehens
strategi shift time would take truli benefit follow
friday call know also work done revit scale
core portfolio cours weve known total re-launch sinc global
consum stapl confer septemb troubl quantifi materi
understand accompani price increas high single-digit
math mean could benefit total compani revenu growth
without assum increment unit/shar growth heel new formul
global advertis campaign wed also note colgat enter charcoal
segment sever market includ us launch tom main charcoal
product would seem good momentum build hill busi
account total compani sale profit strong
quarter prescript diet come re-launch scienc diet new hill
e-commerc subscript servic busi could well reacceler mid
chang model take estim organ growth
vs prior price drive chang yoy volum contribut
rest expect sequenti improv latin america asia-pacif drive bulk
acceler compani lap brazil trucker strike well volum soft
link price initi cours fold estim currenc
 model net sale growth bp expect gross margin
bp posit price product save offset raw materi
currenc inflat model bp expect bp increas
transport logist cost driven inflat advertis bp reflect
increas brand support in-lin level seen prior year
model oper margin bp new ep estim
reflect declin earn yoy in-lin manag guidanc mid single-
digit declin price target cl share reflect multipl
unchang ep estim previous
lauren lieberman herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
